CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in CalciMedica, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- +1 vs. Q4 2024
- Shares held
- 3.97M
- −296.0K (−6.9%) vs. Q4 2024
- Total value
- $7.49M
- −$7.60M (−50.4%) vs. Q4 2024
- New holders
- 4
- 8 more added
- Sold out
- 3
- 6 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CALC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $8.39M |
| Q1 2026 | 27 | $592.5K |
| Q4 2025 | 31 | $24.2M |
| Q3 2025 | 31 | $10.9M |
| Q2 2025 | 30 | $5.93M |
| Q1 2025 | 30 | $7.49M |
| Q4 2024 | 29 | $15.1M |
| Q3 2024 | 24 | $13.6M |
| Q2 2024 | 21 | $11.8M |
| Q1 2024 | 20 | $14.8M |
| Q4 2023 | 12 | $1.49M |
| Q3 2023 | 13 | $1.56M |
| Q2 2023 | 13 | $2.72M |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 27 | $5.97M |
| Q3 2022 | 25 | $10.2M |
| Q2 2022 | 25 | $11.7M |
| Q1 2022 | 27 | $13.5M |
| Q4 2021 | 28 | $20.7M |
| Q3 2021 | 27 | $37.0M |
| Q2 2021 | 41 | $63.7M |
| Q1 2021 | 51 | $72.8M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding CalciMedica, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,300,000 | $2.48M | 0.05% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 783,904 | $1.50M | 0.12% | 00.0% | Unchanged |
| Aisling Capital Management LP | 521,114 | $995.3K | 0.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 339,148 | $647.8K | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 367,371 | $615.1K | 0.71% | −101,422−21.6% | Reduced |
| Wealthedge Investment Advisors, LLC | 108,291 | $206.8K | 0.09% | +80,472+289.3% | Added |
| Geode Capital Management, LLC | 96,382 | $184.1K | 0.00% | +5,516+6.1% | Added |
| Millennium Management LLC | 59,388 | $113.4K | 0.00% | −12,669−17.6% | Reduced |
| Envestnet Asset Management Inc | 59,047 | $112.8K | 0.00% | +12,495+26.8% | Added |
| Meritage Portfolio Management | 46,000 | $87.9K | 0.01% | 00.0% | Unchanged |
| CI Private Wealth, LLC | 38,000 | $72.6K | 0.00% | 00.0% | Unchanged |
| Atria Investments LLC | 37,264 | $71.2K | 0.00% | +3,252+9.6% | Added |
| Renaissance Technologies LLC | 35,416 | $67.6K | 0.00% | −7,784−18.0% | Reduced |
| PVG Asset Management Corp | 30,385 | $58.0K | 0.25% | +30,385 | New |
| Cetera Investment Advisers | 27,340 | $52.2K | 0.00% | +10,467+62.0% | Added |
| Cambridge Investment Research Advisors, Inc. | 23,539 | $45.0K | 0.00% | +23,539 | New |
| J. Goldman & Co LP | 18,900 | $36.1K | 0.00% | 00.0% | Unchanged |
| 180 Wealth Advisors, LLC | 16,400 | $31.3K | 0.00% | +16,400 | New |
| BlackRock, Inc. | 15,407 | $29.4K | 0.00% | −541−3.4% | Reduced |
| Tritonpoint Wealth, LLC | 15,119 | $28.9K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 13,226 | $25.3K | 0.00% | +13,226 | New |
| Bank of America Corp | 9,023 | $17.2K | 0.00% | +40.0% | Added |
| Tower Research Capital LLC (TRC) | 2,982 | $5.70K | 0.00% | +1,758+143.6% | Added |
| Advisor Group Holdings, Inc. | 2,819 | $5.38K | 0.00% | +1,851+191.2% | Added |
| Morgan Stanley | 856 | $1.64K | 0.00% | 00.0% | Unchanged |
| Brown Brothers Harriman & Co | 308 | $588 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 220 | $421 | 0.00% | −105−32.3% | Reduced |
| Federation des caisses Desjardins du Quebec | 200 | $382 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 121 | $231 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 15 | $29 | 0.00% | −2−11.8% | Reduced |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −372,256−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |